1. Home
  2. KVHI vs ENTX Comparison

KVHI vs ENTX Comparison

Compare KVHI & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$7.33

Market Cap

118.4M

Sector

Technology

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.62

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
ENTX
Founded
1978
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.4M
142.0M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
KVHI
ENTX
Price
$7.33
$1.62
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
68.1K
298.4K
Earning Date
03-05-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$107,407,000.00
$124,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$14.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.25
52 Week Low
$4.69
$1.45
52 Week High
$7.69
$3.22

Technical Indicators

Market Signals
Indicator
KVHI
ENTX
Relative Strength Index (RSI) 62.14 40.50
Support Level $7.10 $1.45
Resistance Level $7.69 $1.80
Average True Range (ATR) 0.36 0.19
MACD -0.00 0.00
Stochastic Oscillator 70.18 27.97

Price Performance

Historical Comparison
KVHI
ENTX

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: